Medibank Private (MPL) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
12 Jun, 2026Executive summary
Group operating profit rose 8.9% to $762.4 million, with underlying NPAT up 8.5% to $618.7 million, driven by disciplined growth, claims management, and strong earnings across all segments.
Resident policyholder growth was 1.4% (+27,900), double last year’s rate, with non-resident policy units up 3.1% (+10,500); customer advocacy and retention reached multi-year highs.
Continued investment in health transition, prevention, and mental health, with $50 million committed over five years and expansion of virtual and primary care services.
Medibank Health contributed approximately 10% of group operating profit, with segment profit up 27.0%.
Maintained a strong capital position, supporting ambitions for organic and M&A-driven growth.
Financial highlights
Group revenue from external customers increased 5.2% to $8,604.0 million; health insurance operating profit up 7.1% to $741.5 million.
Medibank Health segment profit surged 27.0% to $76.7 million; Myhealth operating profit up 68.1%.
Net investment income up 14.1% to $207.8 million, with strong performance in both growth and defensive portfolios.
Gross margin improved 50 basis points to 17.0% in health insurance; non-resident gross margin up 270 basis points to 36.9%.
Final fully franked dividend of 10.2 cps, bringing FY25 dividends to 18.0 cps, up 8.4%; payout ratio maintained at 80.1% of underlying NPAT.
Outlook and guidance
Industry growth expected to moderate in FY26, with a focus on disciplined market share gains in both resident and non-resident segments.
Claims per policy unit projected to grow 2.6%-2.9%, with proactive claims management and further investment in customer benefits if claims are lower than expected.
Medibank Health targets low double-digit organic operating profit growth and further M&A to expand scale and capability.
Management expense ratio expected to remain stable or modestly improve, supported by lower inflation and higher revenue growth.
Latest events from Medibank Private
- Operating profit up 6%, Medibank Health profit up 28.5%, and interim dividend up 6.4%.MPL
H1 202612 Jun 2026 - Underlying NPAT up 13.8% and dividend up 8.3% amid strong growth and resilient capital.MPL
H1 202512 Jun 2026 - Underlying NPAT up 14.1%, strong health and non-resident growth, and higher dividends.MPL
H2 202412 Jun 2026 - Strong financials, higher dividends, and digital health focus marked the AGM, with all resolutions passed.MPL
AGM 20243 Feb 2026 - Aims for AUD 200m+ health earnings and 10m engagement by FY30 via tech-enabled, integrated care.MPL
Status Update3 Feb 2026 - Strong growth, board renewal, and strategic health investments marked the AGM.MPL
AGM 202519 Nov 2025 - Medibank drives growth and innovation with resilient operations and expanded healthcare offerings.MPL
Trading Update6 Jun 2025